All Providers

Mr Tolias has been a consultant Neurosurgeon at King’s College Hospital since September 2005.

He has a PhD in Biological Sciences from the University of Warwick and extensive research experience in traumatic brain injury.

Mr Tolias has vast Neurovascular experience and currently has the largest series of aneurysm surgeries in the UK (NNAP 2017).

He specialises in surgery of cerebral aneurysms, arteriovenous malformations, cavernomas and dural fistulas and rare conditions like Moya Moya.

He is one of the few surgeons in the UK who routinely performs cerebral vascular bypasses. He also performed the first ELANA bypass in the UK.

Mr Tolias has pioneered the use of bypass techniques in the management of cerebral vasculopathies.

He is trained in Gamma Knife and Cyberknife and routinely utilises innovative neuromonitoring technologies in the surgery of complex vascular lesions like arteriovenous malformations.

He is one of the few Neurosurgeons nationally who regularly undertakes surgical extirpation of arteriovenous malformations when indicated.

His outcomes are part of national databases and remain among the best in his peer group (NNAP 2017).

Alongside his subspecialty interest Mr Tolias has an active spinal practice dealing with problems of the cervical and lumbar spine. These can include sciatica, brachalgia, radiculopathies and pain management through both injections and radiofrequency ablation as well as surgical interventions.

Mr Tolias is the director of the first and only Royal College of Surgeons of England accredited National Neurovascular Surgical Fellowship based at King’s College Hospital.

He has over 60 papers in peer reviewed journals and more than 150 presentations at conferences. He regularly lectures in the UK and worldwide on topics including complex arteriovenous malformations, aneurysms, Gamma Knife and Cyberknife as well as degenerative spine conditions.

The London Neurosurgery Partnership is a unique concept in the provision of neurosurgical care. The team comprises eleven Consultant Neurosurgeons, all of whom are recognised superspecialists in their given area of expertise. As a result we can ensure that every patient seen by the group is matched with the Consultant Neurosurgeon best placed by virtue of their training and expertise to deliver the individualised and state of the art care each patient deserves.

Working as a team also ensures that our patients can access high quality neurosurgical care at all times from a consultant who will be familiar with their treatment plan at a location convenient to the patient. When appropriate, advice and treatment can be delivered by the composite team.

The London Neurosurgery Partnership has access to all of the latest neurosurgical technologies including the CyberKnife® and Gamma Knife® for radiosurgery which avoids the use of conventional open surgery in some cases and Minimally Invasive Techniques for both Cranial and Spinal neurosurgery when this is not possible. A key aspect of making use of such cutting edge technologies is the decision making process involved and this, in our opinion, is best done by a group of clinicians who are used to working together as a team to ensure that the latest technology and techniques are used appropriately based on the latest clinical guidelines.

Prof Leen currently works as a Consultant Interventional Radiologist at Hammersmith, Charing Cross and St Mary's NHS hospitals, as well as the Princess Grace Hospital privately. He is also Professor of Radiology at Imperial College London and has over 15 years’ experience in ablative therapies.

He leads a clinical ultrasound group with a focus on microbubble ultrasound assessment. He has a specialist interest in ablative therapies for cancer of the kidneys, liver, lung and pancreas and has established and developed a number of percutaneous ablative therapies including the new cancer treatment, NanoKnife, a thermal-based and irreversible electroporation technique. Alongside his interest in novel oncological ablative therapies, Prof Leen has a particular interest in liver imaging, new diagnostic applications in cancer as well as the development of navigation and robotics for percutaneous ablative therapies. He has a long-standing interest in altered hepatic haemodynamics and micro-metastases.

I am a Consultant Interventional Radiologist at Hammersmith Hospital Imperial NHS Trust. My particular interest is in the oncological delivery and treatment of Liver tumours by endovascular means.

Dr Shahid Khan is a Consultant Physician at St Mary’s and Hammersmith Hospitals and a Clinical Senior Lecturer at Imperial College London, having been appointed in 2007. He is a Consultant in Gastroenterology with Specialist Accreditation in Hepatology. He is also a Trainer in Endoscopy.

Background Dr Khan graduated from Guy’s and St Thomas’ Hospitals Medical School in 1994. He completed specialist training in Gastroenterology, Hepatology and General Medicine in 2007 in North-West London and in 2003 he was awarded a PhD from the University of London for studies in liver cancer. Dr Khan became a Fellow of the Royal College of Physicians (FRCP) in 2010.

International Profile Dr Khan has lectured on liver and gastrointestinal disease nationally and internationally at Hepatology and Gastroenterology conferences. He is the lead author on the National guidelines for biliary cancer and was on the European panel for the International guidelines. Dr Khan has also given several presentations and lectures on various aspects of liver and gastrointestinal disease at national and international conferences, including the British of Society Gastroenterology, British and European Associations for the Study of the Liver, the American Association for the Study of the Liver, the International Liver Cancer Association and the Royal Society of Medicine.

Research Dr Khan is the Academic Lead at Imperial College for Liver Cancer. He is also a Senior Lecturer at Imperial College London where he leads a research team investigating early biomarkers in liver disease and supervises several PhD students. His research areas include the epidemiology, aetiopathogenesis, metabolomic, proteomic and genomic analyses of liver cancer. He is recipient of several national research grants. Dr Khan has published over 50 articles in the international medical literature including original research articles, reviews and book chapters.

Dr Rohini Sharma is dual accredited in both medical oncology and clinical pharmacology and is a consultant based at the Hammersmith Hospital.

She completed her medical training at the University of Adelaide, and undertook her specialist oncology training at the Royal Prince Alfred Hospital, Sydney and her clinical pharmacology training at Westmead Hospital, Sydney.

Rohini was awarded an NHMRC PhD Fellowship at the Westmead Millennium Institute, University of Sydney. She was awarded a HEFCE Clinical Senior Lecturer position in May 2010. Rohini's clinical interests are in gastrointestinal malignancies and early phase clinical trials. Her research interests are in PET imaging within the Comprehensive Cancer Imaging Center .

Dr Joy is the Medical Director for the Community Health, Health Promotion and Wellness, Food and Nutrition programs at Intermountain Healthcare in Salt Lake City. In addition she practices Family Medicine and Sports Medicine at the Salt Lake Clinic LiVe Well Center. She is an adjunct faculty member at the University of Utah School of Medicine in the Department of Family and Preventive Medicine and the University of Utah College of Health Department of Nutrition & Integrative Physiology.

Dr. Joy is the Immediate Past President of both the American College of Sports Medicine (ACSM), and the Female Athlete Triad Coalition. She held 2 terms of office on the Board of Trustees for the American Medical Society for Sports Medicine. She is on the Editorial Board for The Clinical Journal of Sports Medicine, and is Associate Editor for Current Sports Medicine Reports. She serves on the Exercise Is Medicine Steering Committee for the ACSM, and chairs the EIM Clinical Practice Committee. In addition, she chairs the Healthcare Workgroup for the National Physical Activity Plan. She developed and directed the Primary Care Sports Medicine Fellowship Program at the University of Utah from 1998 until 2011. Her research and advocacy interests lie in the areas of physical activity assessment and promotion, the Female Athlete Triad, air quality and health, and diabetes prevention.

She has authored many journal articles and textbook chapters on a wide variety of topics in sports medicine. Her research interests lie in the areas of physical activity assessment and promotion, practice-based research in primary care, the Female Athlete Triad, and sports injury prevention.

Steven N. Blair, P.E.D., FACSM, is a Distinguished Professor Emeritus at the Arnold School of Public Health,
Departments of Exercise Science and Epidemiology/Biostatistics at the University of
South Carolina. 

Professor Blair is a past-president of the American College of Sports Medicine (ACSM), National Coalition for Promoting Physical Activity, and the American Academy of Kinesiology and Physical Education as well as co-Chair of the Exercise is Medicine Science Committee.

He has received awards from many professional associations, including a MERIT Award from the National Institutes of Health, an ACSM Honor Award, the Robert Levy Lecture Award, and the Population Research Prize from the American Heart Association.

Professor Blair is also one of the few individuals outside the U.S. Public Health Service to be awarded the U.S. Surgeon General's Medallion. His research focuses on the associations between lifestyle and health, with a specific emphasis on exercise, physical fitness, body composition, and chronic disease. He has published more than 450 papers and chapters in the scientific literature, and served as the senior scientific editor for the U.S. Surgeon General's Report on Physical Activity and Health.

Robert Leonard is a medical oncologist with a major interest in the management of breast cancer. He is a former Professor of Cancer Studies at Imperial College London and honorary consultant medical oncologist at Imperial College NHS Trust; The BUPA Cromwell Hospital, The London Clinic and the London Oncology Clinic. His academic roles have included 25 years in senior Academic and NHS administrative roles in London, Edinburgh and Swansea.

Professor Leonard originally trained and qualified at Charing Cross Hospital, where he was awarded the Clinical Gold Medal and six of the final year prizes. Research Fellowships at Oxford’s Radcliffe Infirmary and Harvard Medical School followed his post-graduate training.

Prior to his roles as Professor of Cancer Studies and Chief of Service for Medical Oncology at Imperial College, he was Professor of Medical Oncology at Swansea Medical School and Director of the South West Wales Cancer Institute.

He is a co-founder and is Medical Director for Maggies’ Cancer Caring Centres UK, and chairs the professional advisory board. Since 2009 he has been Chair of the Scientific Board for Breast Cancer Care UK. He set up and Chairs the International Anglo Celtic Collaborative Oncology Trials Group.

He is author/co-author of more than 350 peer reviewed original papers and reviews. He has been a senior advisor to Cancer Research UK and is lead investigator several previous and current UK clinical Trials. He also regularly acts as expert oncology witness for legal cases.

Dr Iossifidis was educated at the University of Montpellier in France. His postgraduate surgical training took place in Norwich and Cambridge. He then joined the Guy’s and St Thomas’ hospital higher surgical training rotation. As a Senior registrar he developed an interest in shoulder surgery and completed a Shoulder fellowship in London and New York.